Background: The character of immune responses to allergens during the first
Introduction
Allergic diseases are believed to be due to Th2---like immunity to allergens in affected tissue, and immune responses to allergens are characterised by a cross---regulation between Th1 and Th2 cells [1] . Th2 cells produce IgE synthesis inducing IL---4 [2] , eosinophilia promoting IL---5 and IL---9 [3, 4] , while IFN---γ from Th1 cells down---regulates IgE synthesis [2] . Interleukin---9 also enhances IgE production [5] and stimulates T cell and mast cell growth [6, 7] . Interleukin---10 is an anti---inflammatory cytokine, which inhibits both Th1 and Th2 cells and IgE production [8] , as well as shortens eosinophil survival [9] . Less is known about Th1/Th2 development in atopic children.
Prospective studies have shown that IgE antibodies to inhalant allergens are commonly detected both in atopic and non---atopic infants during the first years of life [10] . In non---atopic children, the IgE responses to inhalant allergens are eventually down---regulated, whereas they reach higher levels and tend to persist in atopic children. Furthermore, IgG responses, primarily of the IgG1 subclass to inhalant allergens are also common in infancy, while high levels of IgG4 subclass antibodies to allergens are associated with sensitisation and allergic symptoms [11] . The differences in IgG4 antibody levels to birch in atopic Böttcher and non---atopic children increase from 18 months to 8 years, largely due to a down---regulation of IgG4 antibody responses in the non---atopic children [11] .
It has been demonstrated that birch induced IFN---γ is associated with IgG1
antibody production, while IL---4 production relates to IgG4 antibody subclass responses to Bet v1 [12] . The balance between Th1 and Th2 memory cells, which has been suggested to be set during early life by a process of allergen driven Th1/Th2 selection, might be reflected by these see---sawing IgG subclass and IgE responses to different allergens. Prescott and colleagues, in a prospective two---year follow---up study, demonstrated a persistent proliferative response to house dust mite [13] . The cytokine responses of cord blood mononuclear cells (CBMC)
showed a Th2---skewed profile in all children, but the Th2 responses were lower in individuals who later developed atopic diseases than in those who did not.
Non---atopic individuals showed a gradual decline in detectable IL---4 mRNA and IL---13 protein responses to house dust mite, while atopic individuals had persistent IL---4 mRNA and IL---13 protein responses. There was a similar increase in house dust mite induced IL---6 and IL---10 production in the atopic and non---atopic groups. The IFN---γ mRNA responses were rarely detectable from CBMC but were easily detectable after six months of age in the non---atopic group but not in the atopic group. Böttcher
So far, only allergen specific T---cell responses to house dust mite have been prospectively studied and then only up to two years of age [13] . The aim of this study was therefore to investigate the Th1/Th2 cell selection process to the seasonal inhalant allergen birch over several years. Birch is in some respect a model allergen, as the season of exposure is short, mostly less than six weeks.
Methods

Study group
Twenty---four families with their newborn babies were randomly invited at the maternity clinic at the University Hospital of Linköping, to participate in a prospective study regarding the development of immune responses to birch early in life. All children were born at term from July 1991 to March 1992.
Twenty---one families accepted participation, and their children were followed annually during their first seven years of life. allergic rhinoconjunctivitis, allergic asthma, or flexural itchy dermatitis).
Separation of PBMC
Blood samples were collected in tubes with preservative---free heparin (Beckton 
ELISA for detection of IL---4, IL---5, IL---10, IL---13 and IFN---γ
The levels of IL---4, IL---10, IL---13 and IFN---γ were determined by commercially available ELISA kits (CLB Pelikine Compact™, Research Diagnostics Inc., Flandern, NJ), as described by the manufacturer. The levels of IL---5 were determined using an in---house ELISA as described elsewhere [14] . Briefly, µL/well of a 1.0 µg/mL monoclonal biotinylated rat anti---human IL---5 antibody was used followed by 50 µL/well of streptavidin conjugated polyhorseradish peroxidase (CLB) diluted 1/10 000 in dilution buffer (CLB).
Tetramethylbenzidine (Sigma---Aldrich), 50 µL/well, was used as substrate and addition of 50 µL/well of 1.8M sulphuric acid stopped the reaction. The sensitivity limit for quantitative determinations were 6.25 pg/mL for IL---4 and IL---5, 4.7 pg/ml for IL---10, 62.5 pg/mL for IL---13, and 25 pg/mL for IFN---γ.
RNA extraction and Reverese Transcription PCR of mRNA
Total ribonucleic acid (RNA) was isolated according to the RNeasy® 96
Protocol (Qiagen). In brief, the lysed cells were mixed with ethanol and applied to a RNeasy® 96 well plate. When the membrane had dried, the RNA was eluted in RNAse---free water.
RNA was converted to complimentary DNA using an oligo dT---primer, random decamer primer and M---MLV reverse transcriptase for 1 h at 42°C followed by 10 minutes at 75°C according to the Reverse---it protocol of the supplier (Abgene Advanced Biotechnologies Ltd., Surrey, UK). The samples were run in a GeneAmp PCR System 2400 (Perkin Elmer Applied Biosystems, Foster City, CA, USA). TaqMan probe with the flourophore FAM (6---carboxy---flourescein) at the 5'---end and the quencher TAMRA (6---carboxy---tetramethylrhodamine) at the 3'---end were bought from MedProbe. Both primers and probe were purified with HPLC.
Quantification of IL---4 and IL---9 mRNA with quantitative real time PCR
The wells were covered with optical caps (Perkin Elmer Applied Biosystems), and the plate was centrifuged for some seconds at high speed and thereafter placed into the thermocycler (ABI Prism™ 7700 Sequence Detector, Perkin
Elmer Applied Biosystems). The thermal cycle conditions were 50°C for 2 minutes followed by 95°C for 10 minutes and then 40 cycles were run for 15
seconds at 95°C and for 1 minute at 60°C, as recommended by Perkin Elmer for the SDS 7700 system.
Samples were run with primers and probes for IL---4 or IL---9 and for rRNA in two different wells. The results from the rRNA reactions were used as internal controls, i.e. the amount of IL---4 and IL---9 mRNA was calculated relative to the amount of rRNA present in each sample.
Antibody analyses
Birch specific IgE antibodies were analysed with the high sensitivity protocol of Magic Lite™ according to the recommendations of the manufacturer (ALK).
The determination of IgG subclass antibodies to the recombinant major birch allergen Bet v 1 was performed as described in detail elsewhere [15] . Briefly, microtitre plates were coated with 1µg/ml rBet v 1 (kindly provided by Prof D Kraft, Institute of General and Experimental Pathology, AKH, University of Vienna, Austria) in PBS. Human serum or buffer only was added to duplicate wells followed by monoclonal murine antibodies to human IgG1 (clone HP6069) and IgG4 (clone HP6011), (Bio Zac AB, Järfälla, Sweden). Alkaline phosphatase---conjugated rabbit antimouse IgG (Sigma---Aldrich, Stockholm, Sweden) was then added, and p---nitrophenyl phosphate (Sigma---Aldrich) was used as substrate.
The reference serum, which was calibrated according to a semiquantitative method as described earlier [15] , was from a patient undergoing birch immunotherapy. Values were expressed as arbitrary units (AU) deduced from the ODs of the reference serum curve, after subtracting the blanks.
Samples with undetectable levels of IgG4 antibodies with the conventional ELISA, (described above), were analysed with a more sensitive ELISA [15] . For the substrate reaction an amplified enzyme system, AMPAK (Dakopatts AB, Älvsjö, Sweden), was used.
Pollen counts
Total levels of birch pollen for each year were obtained from the Palynological Laboratory, Swedish Museum of Natural History. Birch pollen was counted in
Norrköping, a city 40 km north of Linköping.
Statistics
As the concentrations of cytokines and antibodies were not normally distributed comparisons between paired groups were analysed using Wilcoxon
Signed rank test and trends over time were analysed using ANOVA for repeated measurements. A probability level of <5% was considered to be statistically significant. Calculations were performed with a statistical package StatView 5.0 for PC (Abacus Concepts Inc., Berkely, California, USA).
Ethics
The Regional Ethics Committee for Human Research at the Linköping
University approved the study.
Results
Sixteen of the children had at least one parent with a history of atopic symptoms (table  2) expression.
IgG1 antibodies to rBet v1 were commonly detected both in atopic and non---atopic infants from the second pollen season and the levels increased with age.
The four children with the highest levels of IgG1 antibodies all had allergic symptoms and two of them were allergic to birch (fig 4a) . In contrast, IgG4
antibodies to rBet v1 were only sporadically demonstrated, and only the two birch allergic children showed high and persistent IgG4 levels (fig  4b) .
The levels of birch specific IgE antibodies in the two birch allergic children, seemed to be related to the counts of birch pollen from the third pollen season in 1994 (fig 1) . There was no association between pollen counts and birch induced proliferation or cytokine production or the levels of IgG antibodies to birch, however (fig  2---4 ).
Discussion
In The failure of immune deviation to allergens among atopic individuals may be associated with poor neonatal capacity to produce IFN---γ [17, 18] . The IFN---γ producing capacity is much lower in neonatal T cells than in adults, and production increases with age [19] . The low IFN---γ production during infancy might be due to postnatal persistence of control mechanisms limiting intrauterine induction of potentially harmful Th1---like immunity [20] . In this prospective study, we show a similar birch induced IFN---γ production in atopic and non---atopic children. This is in agreement with a recent prospective study where house dust mite induced IFN---γ production was low both in atopic and non---atopic children during their first 18 months of life [13] . In that study, however, house dust mite induced IFN---γ mRNA expression increased with age only in the non---atopic individuals.
Although allergen specific Th1---like immunity dominates in healthy individuals, IFN---γ associated delayed type hypersensitivity is not observed. Factors counteracting Th1 reactions are likely to be present and the anti---inflammatory cytokine IL---10 may be one candidate [9] . House dust mite specific IL---10 production from CBMC is upregulated in non---atopic, as compared to atopic, individuals [13] . The age dependent increase of IL---10 production was similar, however, in the two groups. Our results are consistent with that finding, as IL---10 production was detected in all children from the fourth pollen season.
The IL---4, IL---5 and IL---9 responses to birch declined with age, except in the two birch allergic children. The allergen induced production of those cytokines has not previously been prospectively studied at the protein level. Similarly, IL---13
responses declined with age except in one of the two birch allergic children.
Although IL---13 induces IgE switching independently of IL---4 [21] , it is not a typical Th2 cytokine, as both Th1 and Th2 clones produce it and it is not capable Böttcher 20 of inducing Th2 differentiation. No clear difference in IL---13 production was observed between atopic and non---atopic children in this study. In contrast, house dust mite induced IL---13 production is down---regulated in non---atopic children, whereas the opposite was observed for atopic children, independently of what allergen the child was sensitised against [13] . There are, however, also differences in the methodology. In the study by Prescott et al, the cells were incubated with allergen for 24 h, in contrast to 96 h in our study. It has earlier been shown that allergen induced IL---13, as well as IL---5 and IFN---γ production increase over time and that the levels and number of individuals with detectable levels were significantly higher after 96 h, as compared to 24 h, of incubation [12] . Furthermore, the atopic status of the children in the study by
Prescott et al was based on a two---year follow---up whereas the children in our study were followed during their first seven years of life.
The IgG responses to Bet v 1 were largely restricted to the IgG1 subclass, confirming the findings in a previous cohort [15] . The IgG1 responses were commonly seen, regardless of atopic symptoms and sensitisation but, as reported previously, they were higher in atopic children [15, 22] . Similar to findings in another cohort [11] , there was an even stronger relationship between Th2 associated IgG4 antibodies and atopy. In that study, the differences in IgG4
antibody levels between atopic and non---atopic children were greater at 8 years than at 18 months, which was largely due to down---regulation of IgG4 antibody responses in non---atopic children. This is supported by the findings in the present study.
The period when allergen driven Th1/Th2 selection occurs, the so---called ''window of sensitisation'' has been suggested to occur during a narrow period after birth [23] . We have with this study extended this hypothesis to suggest that this may last for around 3---4 years after birth, at least for a seasonal allergen with a short period of exposure every year. Table 2 . Data regarding development of atopic dermatitis (AD), allergic rinoconjuntivitis (ARC) and asthma (AB) and skin prick test (SPT) positivity in the individual babies and the symptoms reported in the mother (M) and father (F).
